Skip to main content
. 2022 Mar 11;17(3):e0264909. doi: 10.1371/journal.pone.0264909

Fig 2. Compounds reported in the manuscripts reviewed.

Fig 2

Ten compounds were used as CRH-R1 selective antagonists, while only two compounds were used as CRH-R2. Three non-selective CRH-R antagonists were reported in the studies.

HHS Vulnerability Disclosure